Archive
This is a library of Lhasa's blog articles.
Filter by Category
Filter by Author
- Alex Cayley
- Alex Harding
- Alun Myden
- Anax Oliveira
- Andrew Thresher
- Ash Ali
- Chris Barber
- Crina Heghes
- Dave Yeo
- David Ponting
- Grace Kocks
- Hazel Gardiner
- Kelly Gallagher
- Laura Johnston
- Liz Covey-Crump
- Michael Burns
- Nik Marchetti
- Paul Imeson
- Pearl Saville
- Rachael Tennant
- Rob Foster
- Scott McDonald
- Susanne Stalford
Filter by Product
It Takes a Team to Build an Adverse Outcome Pathway
The saying goes, “It takes a village to raise a child”. This sentiment can be translated to the work we do at Lhasa Limited, particularly to the work which we put into building Adverse Outcome Pathways (AOPs). To echo the sentiment in Chris Barber’s previous blog post, The challenge of building QSAR models; it is easy to build an AOP, harder to build a useful AOP, and as for building an AOP you can trust? It takes a team.
Read about how we are building adverse outcome pathways (AOPs) at Lhasa in this blog post written by Dr. Susanne Stalford, Senior Scientist at Lhasa.
30 September 2020
The Application of Adverse Outcome Pathways (AOPs) for Risk Assessment (A Webinar Summary)
AOPs have the potential to be very powerful for the contextualisation of alternative assays and consequently for the management of alternative testing strategies. Read about what Lhasa is doing in this area in this blog piece written by Alun Myden, Senior Scientist at Lhasa.
03 July 2020